Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Rare Diseases

EU Partner

An Introduction to Rare Diseases

Rare respiratory conditions encompass a spectrum of pulmonary disorders that affect a limited number of individuals, often presenting significant challenges due to their scarcity and complexity. These conditions, including interstitial lung diseases, pulmonary vascular disorders, and rare genetic respiratory disorders, pose unique diagnostic and therapeutic challenges.

Current treatments for these conditions often involve symptom management and supportive care, but the evolving landscape of pulmonary medicine is witnessing promising advancements. Emerging therapies, including precision medicine approaches and targeted treatments, are offering new avenues for managing these conditions.

Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.

Our supporting partners do not constitute an endorsement of the content on this page.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

64 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS
Prof. Tahseen Mozaffar, Dr Jennifer L Cohen, Prof. Benedikt Schoser

Leading experts in Pompe disease explore key data from WMS 2024 and WORLDSymposium 2025.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar

Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

31 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono

Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

Close Popup